Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Biocon to invest in...

    Biocon to invest in Uttar Pradesh health sector

    Written by Ruby Khatun Khatun Published On 2017-12-26T10:56:44+05:30  |  Updated On 26 Dec 2017 10:56 AM IST
    Biocon to invest in Uttar Pradesh health sector

    BENGALURU: Biocon Ltd, a biopharma company is going to invest in the health sector of Uttar Pradesh to encourage the startups and entrepreneurs in the biotech areas to work in the state.


    Kiran Mazumdar-Shaw, CEO of Biocon met with industrial development minister of UP Satish Mahana and other senior officials of UP government during a road show organized by UP government in Bengaluru as a pioneer to the investors' summit in February 2018 where she said that she will invest in the health sector of UP.


    A member of UP delegation told TOI, "She said that a survey should be conducted in all districts of UP, including Gorakhpur, for starting e-health care centres under a pilot project. She further suggested that a campaign be launched to attract investors in the health sector."


    The road show in Bengaluru was the second of six road shows being organized by the UP government across India to build up to the main event in Lucknow on February 21-22, 2018.


    Satish Mahana told TOI, "UP has increased the limit of start-up corpus fund from Rs 100 crore to Rs 1,000 crore. Exemptions have been provided in electricity bills, reimbursement of provident fund and a self-attestation system will remain in force as these were in force prior to the introduction of the new policy."


    Infrastructure and Industrial Development Commissioner Anup Chandra Pandey said,"Project developers will be provided with 'no-objection certificates', a full exemption in stamp fee and electricity cess for 10 years on purchasing ceiling land of at least 5.058 hectares. All solar energy generation projects will be given exemption from obtaining environmental NOC," he said.

    BengaluruBioconBiocon Ltdbiopharma companyentrepreneurshealth sectorindustrial development minister of UPinvestinvestors summitKiran Mazumdar Shawroad showSatish MahanastartupsUPUttar Pradesh
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok